Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

404 ARTÍCULOS , VIENDO DEL 256 AL 270

Alzheimer's disease and its treatment by different approaches: A review

Srivastava S, Ahmad R, Khare SK.

Eur J Med Chem. 2021 Apr 15;216:113320. doi: 10.1016/j.ejmech.2021.113320. Epub 2021 Feb 23.

Association between CSF Aβ42 and amyloid negativity in patients with different stage mild cognitive impairment

He B, Wang L, Xu B, Zhang Y; Alzheimer’s Disease Neuroimaging Initiative.

Neurosci Lett. 2021 May 29;754:135765. doi: 10.1016/j.neulet.2021.135765. Epub 2021 Mar 2.

Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring

van Oostveen WM, de Lange ECM.

Int J Mol Sci. 2021 Feb 20;22(4):2110. doi: 10.3390/ijms22042110.

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

Leuzy A, Ashton NJ, Mattsson-Carlgren N, Dodich A, Boccardi M, Corre J, Drzezga A, Nordberg A, Ossenkoppele R, Zetterberg H, Blennow K, Frisoni GB, Garibotto V, Hansson O.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2121-2139. doi: 10.1007/s00259-021-05258-7. Epub 2021 Mar 5.

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers

Ashton NJ, Leuzy A, Karikari TK, Mattsson-Carlgren N, Dodich A, Boccardi M, Corre J, Drzezga A, Nordberg A, Ossenkoppele R, Zetterberg H, Blennow K, Frisoni GB, Garibotto V, Hansson O.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2140-2156. doi: 10.1007/s00259-021-05253-y. Epub 2021 Mar 6.

An Introduction to Ultrasensitive Assays for Plasma Tau Detection

Ding XL, Tuo QZ, Lei P.

J Alzheimers Dis. 2021;80(4):1353-1362. doi: 10.3233/JAD-201499.

Molecular imaging and fluid biomarkers of Alzheimer's disease neuropathology: an opportunity for integrated diagnostics

Garibotto V, Boccardi M, Chiti A, Frisoni GB.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2067-2069. doi: 10.1007/s00259-020-05116-y.

Blood tests to screen for Alzheimer's disease

Husain M.

Brain. 2021 Mar 3;144(2):355-356. doi: 10.1093/brain/awaa462.

Therapy for Alzheimer's disease: Missing targets and functional markers?

Stoiljkovic M, Horvath TL, Hajós M.

Ageing Res Rev. 2021 Jul;68:101318. doi: 10.1016/j.arr.2021.101318. Epub 2021 Mar 9.

Microglia Biomarkers in Alzheimer's Disease

Zhang PF, Hu H, Tan L, Yu JT.

Mol Neurobiol. 2021 Jul;58(7):3388-3404. doi: 10.1007/s12035-021-02348-3. Epub 2021 Mar 12.

Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

Chiotis K, Dodich A, Boccardi M, Festari C, Drzezga A, Hansson O, Ossenkoppele R, Frisoni G, Garibotto V, Nordberg A.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2086-2096. doi: 10.1007/s00259-021-05277-4. Epub 2021 Mar 15.

Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study

Liu G, Liu C, Qiu A; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2021 Jun 15;42(9):2931-2940. doi: 10.1002/hbm.25414. Epub 2021 Mar 19.

Fluid Biomarkers in Clinical Trials for Alzheimer's Disease: Current and Future Application

Yang J, Jia L, Li Y, Qiu Q, Quan M, Jia J.

J Alzheimers Dis. 2021;81(1):19-32. doi: 10.3233/JAD-201068.

Advances in the development paradigm of biosample-based biosensors for early ultrasensitive detection of alzheimer's disease

Karki HP, Jang Y, Jung J, Oh J.

J Nanobiotechnology. 2021 Mar 9;19(1):72. doi: 10.1186/s12951-021-00814-7.

Research diagnostic criteria for Alzheimer's disease: findings from the LipiDiDiet randomized controlled trial

Rosenberg A, Solomon A, Soininen H, Visser PJ, Blennow K, Hartmann T, Kivipelto M; LipiDiDiet clinical study group.

Alzheimers Res Ther. 2021 Mar 25;13(1):64. doi: 10.1186/s13195-021-00799-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias